Skip to main content

Advertisement

Table 1 Baseline patient and disease characteristics and treatment approach with SIRT according to the number of procedures with each application agent

From: Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration

  Sterile water Isotonic 5 % glucose (G5W) p value*
Gender, n (%)    ns
 Male:female (procedure based) 28:22 33:21  
 Male:female (patient based) 12:12 18:11  
Mean age, years    ns
 Procedure based 61 65  
 Patient based 60.5 66  
Older than 65 years old, n (%)    ns
 Procedure based 16 (32 %) 25 (46.8 %)  
 Patient based 7 (29 %) 15 (52 %)  
Primary tumor origin, n (%)    
 Procedure based    
  Colorectal cancer 15 14 ns
  Hepatocellular carcinoma 11 14
  Neuroendocrine tumor 9 13
  Breast cancer 9 7
  Cholangiocarcinoma 4 2
  Others 2 4
 Patient based   
  Colorectal cancer 5 7
  Hepatocellular carcinoma 6 7
  Neuroendocrine tumor 4 8
  Breast cancer 4 2
  Cholangiocarcinoma 3 1
  Others 2 4
Prior TACE 6 9 ns
Activity planned GBq, median (range)    ns
 Procedure based 1.54 GBq (0.5–2.5) 1.45 GBq (0.5–2.4)
 Patient based 1.5 (0.56–2.1) 1.4 (0.6–2.4)
Activity delivered GBq, median (range)    
 Procedure based 1.05 (0.2–2.29) 1.2 (0.3–2.4) 0.04
 Patient based 1.0 (0.4–2.1) 1.4 (0.6–2.4) 0.005
Treatment approach, n (%)    ns
 Whole-liver treatment 11 8
 Lobar 38 43
 Segmental 1 3
  1. *Chi-square test